-
Something wrong with this record ?
SMARCA4-Deficient Carcinoma of Uterine Cervix Resembling SCCOHT-Case Report
I. Sirák, J. Laco, H. Vošmiková, LK. Mell, FG. Herrera, M. Šenkeříková, M. Vošmik
Language English Country Switzerland
Document type Case Reports
NLK
Directory of Open Access Journals
from 2021
PubMed Central
from 2021
ProQuest Central
from 2021-01-01 to 2021-09-30
Medline Complete (EBSCOhost)
from 2014-01-01
Nursing & Allied Health Database (ProQuest)
from 2021-01-01 to 2021-09-30
Health & Medicine (ProQuest)
from 2021-01-01 to 2021-09-30
ROAD: Directory of Open Access Scholarly Resources
from 1995
- MeSH
- DNA Helicases deficiency genetics MeSH
- Fatal Outcome MeSH
- Hypercalcemia diagnosis genetics metabolism therapy MeSH
- Nuclear Proteins deficiency genetics MeSH
- Humans MeSH
- Carcinoma, Small Cell diagnosis genetics metabolism therapy MeSH
- Adolescent MeSH
- Mutation MeSH
- Biomarkers, Tumor deficiency genetics MeSH
- Uterine Cervical Neoplasms diagnosis genetics metabolism therapy MeSH
- Transcription Factors deficiency genetics MeSH
- Check Tag
- Humans MeSH
- Adolescent MeSH
- Female MeSH
- Publication type
- Case Reports MeSH
Small cell carcinoma of hypercalcemic type (SCCOHT) is a rare gynaecological neoplasm, originating mostly in the ovaries. Cervical origin of this very aggressive malignancy with unknown histogenesis is an extremely rare condition, without published management recommendations. Alterations in SMARCA4 gene are supposed to play the major role in SCCOHT oncogenesis and their identification is crucial for the diagnosis. Adequate genetic counselling of the patients and their families seems to be of great importance. Optimal management and treatment approaches are not known yet but may extremely influence the prognosis of young female patients that suffer from this very resistant disease. Nowadays, a translational research seems to be the key for the further diagnostic and treatment strategies of SCCOHT. The purpose of the case report is to provide practical information and useful recommendations on the diagnosis, management, and treatment of SMARCA4-deficient carcinoma of the uterine cervix resembling SCCOHT.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011699
- 003
- CZ-PrNML
- 005
- 20220506131037.0
- 007
- ta
- 008
- 220425s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/pore.2021.1610003 $2 doi
- 035 __
- $a (PubMed)34970085
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Sirák, Igor $u Department of Oncology and Radiotherapy, Faculty of Medicine and University Hospital, Charles University, Hradec Kralove, Czechia
- 245 10
- $a SMARCA4-Deficient Carcinoma of Uterine Cervix Resembling SCCOHT-Case Report / $c I. Sirák, J. Laco, H. Vošmiková, LK. Mell, FG. Herrera, M. Šenkeříková, M. Vošmik
- 520 9_
- $a Small cell carcinoma of hypercalcemic type (SCCOHT) is a rare gynaecological neoplasm, originating mostly in the ovaries. Cervical origin of this very aggressive malignancy with unknown histogenesis is an extremely rare condition, without published management recommendations. Alterations in SMARCA4 gene are supposed to play the major role in SCCOHT oncogenesis and their identification is crucial for the diagnosis. Adequate genetic counselling of the patients and their families seems to be of great importance. Optimal management and treatment approaches are not known yet but may extremely influence the prognosis of young female patients that suffer from this very resistant disease. Nowadays, a translational research seems to be the key for the further diagnostic and treatment strategies of SCCOHT. The purpose of the case report is to provide practical information and useful recommendations on the diagnosis, management, and treatment of SMARCA4-deficient carcinoma of the uterine cervix resembling SCCOHT.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a nádorové biomarkery $x nedostatek $x genetika $7 D014408
- 650 _2
- $a malobuněčný karcinom $x diagnóza $x genetika $x metabolismus $x terapie $7 D018288
- 650 _2
- $a DNA-helikasy $x nedostatek $x genetika $7 D004265
- 650 _2
- $a fatální výsledek $7 D017809
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hyperkalcemie $x diagnóza $x genetika $x metabolismus $x terapie $7 D006934
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a jaderné proteiny $x nedostatek $x genetika $7 D009687
- 650 _2
- $a transkripční faktory $x nedostatek $x genetika $7 D014157
- 650 _2
- $a nádory děložního čípku $x diagnóza $x genetika $x metabolismus $x terapie $7 D002583
- 655 _2
- $a kazuistiky $7 D002363
- 700 1_
- $a Laco, Jan $u The Fingerland Department of Pathology, Faculty of Medicine and University Hospital, Charles University, Hradec Kralove, Czechia
- 700 1_
- $a Vošmiková, Hana $u The Fingerland Department of Pathology, Faculty of Medicine and University Hospital, Charles University, Hradec Kralove, Czechia
- 700 1_
- $a Mell, Loren K $u Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, CA, United States
- 700 1_
- $a Herrera, Fernanda G $u Ludwig Institute for Cancer Research, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland
- 700 1_
- $a Šenkeříková, Mária $u Department of Medical Genetics, Faculty of Medicine and University Hospital, Charles University, Hradec Kralove, Czechia
- 700 1_
- $a Vošmik, Milan $u Department of Oncology and Radiotherapy, Faculty of Medicine and University Hospital, Charles University, Hradec Kralove, Czechia
- 773 0_
- $w MED00180530 $t Pathology oncology research : POR $x 1532-2807 $g Roč. 27, č. - (2021), s. 1610003
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34970085 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506131029 $b ABA008
- 999 __
- $a ok $b bmc $g 1789342 $s 1162897
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 27 $c - $d 1610003 $e 20211214 $i 1532-2807 $m Pathology oncology research $n Pathol Oncol Res $x MED00180530
- LZP __
- $a Pubmed-20220425